Monthly Archives: December 2011

Transplant candidates seek best quality livers, even if it means waiting longer

Liver transplantation candidates want to be involved in decisions regarding quality of the donor organ, and many are reluctant to accept organs with a higher risk of failure, according to research conducted by physicians and experts at the University of Michigan in Ann Arbor.  More than 42% of patients would choose to remain on the [Sign in to read the full article...]

FDA approves mechanical cardiac assist device for children with heart failure

The US Food and Drug Administration (FDA) announced it has approved a medical device that supports the weakened heart of children with heart failure to keep them alive until a donor for a heart transplant can be found.    The mechanical pulsatile cardiac assist device is called the EXCOR Pediatric System, and is made by Berlin [Sign in to read the full article...]

HIV drug reduces graft-versus-host disease in stem cell transplant patients, study finds

An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease (GvHD) in blood cancer patients following allogeneic stem cell transplantation, according to new research from the Perelman School of Medicine at the University of Pennsylvania.  Standard GvHD treatments suppress the immune system, reducing—but not eliminating—the risk of developing [Sign in to read the full article...]

UPMC to collaborate with Singapore’s Asian Centre for Liver Diseases & Transplantation

The Asian Centre for Liver Diseases & Transplantation (ACLDT), based in Singapore, and the University of Pittsburgh Medical Center (UPMC) announced they have signed an interim service agreement to collaborate on the establishment of a comprehensive transplant center that will service patients throughout Asia and the Middle East. ACLDT, established in 1994, is one of [Sign in to read the full article...]

Liver transplants in patients with non alcoholic steatohepatitis increased six-fold in past 15 years

The frequency of liver transplantation for nonalcoholic steatohepatitis (NASH) has increased six fold over the past 15 years and recipients are living longer compared with other liver transplant patients, according to data compiled by the United Network for Organ Sharing (UNOS).  The cause of the increase was attributed to the obesity epidemic in the US [Sign in to read the full article...]